An Asia-Pacific first, a microsurgical procedure using the cutting-edge Symani Robotic Surgical System, developed by surgical robotics company MMI (Medical Micro Instruments), has been achieved at St Vincent’s Hospital Melbourne.

The landmark surgery was a cancer reconstruction of the lower limb and represents a significant advancement in the field of microsurgery.

The Symani system is a teleoperated system, available in Australia with medical equipment supplier Device Technologies, that mimics a surgeon’s hand movements, enhances the ability to perform intricate operations on vessel structures that can be smaller than a millimetre, providing access to challenging anatomical areas.

The system’s tiny robotic instruments are designed to enhance precision during surgeries and handle delicate parts with increased dexterity, making it ideal for complex procedures such as cancer reconstruction, nerve repair, soft tissue, and lymphatic repair.

The technology is designed to equip surgeons with greater capabilities to perform complex reconstructive procedures, which previously may not have been possible, and may open up a gateway for patients with no traditional surgical options.

“This technology will revolutionise microsurgery and change how we repair things. This new system expands on St Vincent’s use of robotic technologies for patient treatment and strengthens our hospital’s position as a global centre for excellence in robotic-assisted surgeries,” says Eldon Mah, a reconstructive surgeon at St Vincent’s Hospital Melbourne.

St Vincent’s Hospital Melbourne will initially use the Symani technology for procedures including breast, sarcoma, and head and neck cancer reconstruction, digit replantation, and treatment for lymphedema.

As one of only 21 global sites using this advanced robotic technology, St Vincent’s will serve as an observation and educational hub for the southern hemisphere, further cementing its reputation as a leader in robotic-assisted surgeries.

“The introduction of the Symani system is a major milestone for Australian Healthcare. St Vincent’s has shown what the future can hold when it comes to setting a new standard for surgical precision in complex, microsurgical procedures – we hope this can pave the way for further adoption and innovation.” Lisa Kirsch, Director of Sales – Surgical & Hospital, Device Technologies.